Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal origin

Stem Cells

Volumn 31, Issue 7, 2013, Pages 1363-1370

  Sipos, Peter I ^a   Rens, Willem ^b   Schlecht, Hé Lène ^c   Fan, Xiaohu ^d   Wareing, Mark ^a   Hayward, Christina ^a   Hubel, Carl A ^e   Bourque, Stephane ^d   Baker, Philip N ^d   Davidge, Sandra T ^d   Sibley, Colin P ^a   Crocker, Ian P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chimerism; Circulation; Maternal Fetal Exchange; Neovascularization; Physiologic; Uteroplacenta

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; ENHANCED GREEN FLUORESCENT PROTEIN; TESTIS DETERMINING FACTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CHIMERA; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIAL COLONY FORMING CELL; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS GROWTH; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PREGNANCY; PROTEIN EXPRESSION; SCID MOUSE; UTERINE CERVIX EPITHELIUM; Y CHROMOSOME;

EID: 84879931594     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1385     Document Type: Article

References (61)

1. Berg CJ, Mackay AP, Qin C et al. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol 2009;113:1075-1081.
2. Mikolajczyk RT, Zhang J, Betran AP et al. A global reference for fetal- weight and birthweight percentiles. Lancet 2011;377:1855-1861.
3. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): Epidemiology and etiology. Pediatr Endocrinol Rev 2009; 6(suppl 3):332-336.
4. Barker DJ, Osmond C, Forsen TJ et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005;353: 1802-1809.
5. Fraser A, Nelson SM, Macdonald-Wallis C et al. Associations of pregnancy complications with calculated CVD risk and cardiovascular risk factors in middle age: The Avon Longitudinal Study of Parents and Children. Circulation 2012;15:1367-1380.
6. Sipos P, Hubel C, Wareing M et al. Fetal-derived endothelial progenitor cells may contribute to placental vasculature and the pathogenesis of IUGR. Placenta 2010;31:A36-A36.
7. Lin Y, Weisdorf DJ, Solovey A et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77.
8. Sipos P, Davidge S, Baker P et al. The role of fetal endothelial progenitor cells (EPCs) in placental vasculogenesis. Reprod Sci 2011;18: 71A-71A.
9. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85: 221-228.
10. Robb AO, Mills NL, Smith IB et al. Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod 2009;24: 619-625.
11. Sugawara J, Mitsui-Saito M, Hoshiai T et al. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab 2005;90:1845-1848.
12. Luppi P, Powers RW, Verma V et al. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 2010;17:643-652.
13. Ligi I, Simoncini S, Tellier E et al. A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants. Blood 2011;118:1699-1709.
14. Sipos PI, Crocker IP, Hubel CA et al. Endothelial progenitor cells: Their potential in the placental vasculature and related complications. Placenta 2010;31:1-10.
15. Baker CD, Ryan SL, Ingram DA et al. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 2009;180:454-461.
16. Ingram DA, Mead LE, Tanaka H et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760.
17. Au P, Daheron LM, Duda DG et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008;111:1302-1305.
18. Mead LE, Prater D, Yoder MC et al. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol 2008;Chapter 2:Unit 2C 1.
19. Williamson K, Stringer SE, Sipos P et al. 40 Age-related modification of heparan sulphate proteoglycans on human endothelial progenitor cells. Heart 2011;97:e7.
20. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004;25:103-113.
21. Mandala M, Osol G. Physiological remodelling of the maternal uterine circulation during pregnancy. Basic Clin Pharmacol Toxicol 2012;110: 12-18.
22. Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda) 2009;24:58-71.
23. Chen JZ, Sheehan PM, Brennecke SP et al. Vessel remodelling, pregnancy hormones and extravillous trophoblast function. Mol Cell Endocrinol 2012;349:138-144.
24. Zhou Y, Genbacev O, Fisher SJ. The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 2003;995:73-83.
25. Soares MJ, Chakraborty D, Renaud SJ et al. Regulatory pathways controlling the endovascular invasive trophoblast cell lineage. J Reprod Dev 2012;58:283-287.
26. Pijnenborg R, Vercruysse L, Brosens I. Deep placentation. Best Pract Res Clin Obstet Gynaecol 2011;25:273-285.
27. Adamson SL, Lu Y, Whiteley KJ et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002;250:358-373.
28. Ji L, Brkic J, Liu M et al. Placental trophoblast cell differentiation: Physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med 2012 [Epub ahead of print].
29. Ellis N, Innes BA, Lash GE et al. Loss of endothelial cells in spiral artery remodeling: Myths versus facts. Placenta 2011;32:A76-A76.
30. Lissauer DM, Piper KP, Moss PA et al. Fetal microchimerism: The cellular and immunological legacy of pregnancy. Expert Rev Mol Med 2009;11:e33.
31. Tower CL, Lui S, Charlesworth NR et al. Differential expression of angiotensin II type 1 and type 2 receptors at the maternal-fetal interface: Potential roles in early placental development. Reproduction 2010;140:931-942.
32. Boon EM, Schlecht HB, Martin P et al. Y chromosome detection by real time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma. Prenat Diagn 2007;27:932-937.
33. Nguyen Huu S, Oster M, Uzan S et al. Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci USA 2007;104:1871-1876.
34. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
35. Hutchinson ES, Brownbill P, Jones NW et al. Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. Placenta 2009;30:634-641.
36. Ashley RL, Antoniazzi AQ, Anthony RV et al. The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep. Reprod Biol Endocrinol 2011;9:148.
37. Hwang HS, Kwon HS, Sohn IS et al. Increased CXCL12 expression in the placentae of women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2012;160:137-141.
38. Kitaya K, Yamada H. Pathophysiological roles of chemokines in human reproduction: An overview. Am J Reprod Immunol 2011;65: 449-459.
39. Wellings RP, Lash GE, Murray JC et al. Endothelial monocyteactivating polypeptide-2 is increased in pregnancy but is not further increased in preeclampsia. J Soc Gynecol Investig 1999;6: 142-146.
40. Vuorela P, Hatva E, Lymboussaki A et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997;56:489-494.
41. Yoon CH, Hur J, Park KW et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-1627.
42. Bompais H, Chagraoui J, Canron X et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004; 103:2577-2584.
43. Egorova AD, DeRuiter MC, de Boer HC et al. Endothelial colonyforming cells show a mature transcriptional response to shear stress. In Vitro Cell Dev Biol Anim 2012;48:21-29.
44. Ladhoff J, Fleischer B, Hara Y et al. Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res 2010;88:121-129.
45. Margheri F, Chilla A, Laurenzana A et al. Endothelial progenitor celldependent angiogenesis requires localization of the full-length form of uPAR in caveolae. Blood 2011;118:3743-3755.
46. Schwarz TM, Leicht SF, Radic T et al. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler Thromb Vasc Biol 2012;32:e13-e21.
47. Basire A, Sabatier F, Ravet S et al. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost 2006;95:678-688.
48. Kusuma S, Zhao S, Gerecht S. The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J 2012;26:4925-4936.
49. Bianchi DW, Williams JM, Sullivan LM et al. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997;61:822-829.
50. Khosrotehrani K, Johnson KL, Cha DH et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004;292:75-80.
51. Tower C, Crocker I, Chirico D et al. SLE and pregnancy: The potential role for regulatory T cells. Nat Rev Rheumatol 2011;7:124-128.
52. Bonilla WV, Geuking MB, Aichele P et al. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006;116:156-162.
53. Piper KP, McLarnon A, Arrazi J et al. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007;76:96-101.
54. Smadja DM, Bieche I, Emmerich J et al. PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood. J Thromb Haemost 2006;4: 2729-2731.
55. Smadja DM, Mauge L, Susen S et al. Blood outgrowth endothelial cells from cord blood and peripheral blood: Angiogenesis-related characteristics in vitro: A rebuttal. J Thromb Haemost 2009;7:504-506; author reply 506-508.
56. Sugawara J, Mitsui-Saito M, Hayashi C et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005;90:5329-5332.
57. Kwon JY, Maeng YS, Kwon YG et al. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol Obstet Invest 2007;64:103-108.
58. Xia L, Zhou XP, Zhu JH et al. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J Obstet Gynaecol Res 2007;33:465-474.
59. Hwang HS, Kwon YG, Kwon JY et al. Senescence of fetal endothelial progenitor cell in pregnancy with idiopathic fetal growth restriction. J Matern Fetal Neonatal Med 2012;25:1769-1773.
60. Gruslin A, Lemyre B. Pre-eclampsia: Fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol 2011;25:491-507.
61. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.